Cargando…

Benefits of basil tea for patients with differentiated thyroid cancer during radioiodine therapy: A randomized controlled trial

BACKGROUND: Acute sialadenitis is one of the major physical complications of radioactive iodine therapy (RAIT) for differentiated thyroid cancer (DTC). It is considered necessary to pay attention to the psychological impact on the patient as well as the physical influence during RAIT. OBJECTIVE: To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nomura, Kenta, Nakayama, Michihiro, Okizaki, Atsutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565770/ https://www.ncbi.nlm.nih.gov/pubmed/37829808 http://dx.doi.org/10.1016/j.heliyon.2023.e20691

Ejemplares similares

A Randomized Controlled Trial for the Effectiveness of Aromatherapy in Decreasing Salivary Gland Damage following Radioactive Iodine Therapy for Differentiated Thyroid Cancer
por: Nakayama, Michihiro, et al.
Publicado: (2016)

Fasting Hypoglycemia on (18)F-FDG PET/CT Scan
por: Nakayama, Michihiro, et al.
Publicado: (2017)

A Quantitative Evaluation of Hepatic Uptake on I-131 Whole-Body Scintigraphy for Postablative Therapy of Thyroid Carcinoma
por: Nakayama, Michihiro, et al.
Publicado: (2015)

A novel iterative modified bicubic interpolation method enables high-contrast and high-resolution image generation for F-18 FDG-PET
por: Okizaki, Atsutaka, et al.
Publicado: (2017)

Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions
por: Nakayama, Michihiro, et al.
Publicado: (2012)

Comparison of pain-relieving effects by number of irradiations, through propensity score matching and the international consensus endpoint
por: Aoki, Yuki, et al.
Publicado: (2023)

Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer
por: Pacilio, Massimiliano, et al.
Publicado: (2022)

Radioiodine adjuvant therapy in differentiated thyroid cancer: An update and reconsideration
por: Sun, Yu-qing, et al.
Publicado: (2022)

Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
por: Chung, June-Key, et al.
Publicado: (2014)

False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
por: Barbaro, Daniele, et al.
Publicado: (2023)

Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial
por: Kiyota, Naomi, et al.
Publicado: (2017)

Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit
por: Wirth, Lori J, et al.
Publicado: (2022)

Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer
por: Herranz, Urbano Anido
Publicado: (2022)

Oxidative stress and radioiodine treatment of differentiated thyroid cancer
por: Buczyńska, Angelika, et al.
Publicado: (2021)

Feasibility of Apatinib in Radioiodine-Refractory Differentiated Thyroid Carcinoma
por: Du, Wei, et al.
Publicado: (2022)

Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
por: Petranović Ovčariček, Petra, et al.
Publicado: (2023)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
por: Hong, Chae Moon, et al.
Publicado: (2017)

Radioiodine refractoriness score: A multivariable prediction model for postoperative radioiodine‐refractory differentiated thyroid carcinomas
por: Li, Genpeng, et al.
Publicado: (2018)

Distinguishing Patients With Distant Metastatic Differentiated Thyroid Cancer Who Biochemically Benefit From Next Radioiodine Treatment
por: Sa, Ri, et al.
Publicado: (2020)

The EANM guideline on radioiodine therapy of benign thyroid disease
por: Campennì, Alfredo, et al.
Publicado: (2023)

Recombinant Human Thyrotropin-Aided Radioiodine Therapy in Patients with Metastatic Differentiated Thyroid Carcinoma
por: Zagar, Ivana, et al.
Publicado: (2012)

Alterations in Oral Microbiota of Differentiated Thyroid Carcinoma Patients With Xerostomia After Radioiodine Therapy
por: Lin, Baiqiang, et al.
Publicado: (2022)

Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease
por: Busaidy, Naifa Lamki, et al.
Publicado: (2012)

Faecalibacterium prausnitzii in Differentiated Thyroid Cancer Patients Treated with Radioiodine
por: Fernandes, Ana, et al.
Publicado: (2023)

The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma
por: Dizdarevic, S, et al.
Publicado: (2019)

Does Radioiodine Therapy in Patients with Differentiated Thyroid Cancer Increase the Frequency of Another Malignant Neoplasm?
por: Hirosawa, Renata Midori, et al.
Publicado: (2011)

Bone marrow suppression in pediatric patients with differentiated thyroid cancer following empirical radioiodine therapy
por: Dong, Ping, et al.
Publicado: (2020)

Dacryoendoscopic recanalization of lacrimal passage obstruction/stenosis after radioiodine therapy for differentiated thyroid carcinoma
por: Inomata, Daniela, et al.
Publicado: (2022)

Development and validation of nomograms for predicting survival in differentiated thyroid cancer patients with or without radioiodine therapy
por: Ran, Bingyu, et al.
Publicado: (2023)

Dietary Iodine Intake, Therapy with Radioiodine, and Anaplastic Thyroid Carcinoma
por: Besic, Nikola, et al.
Publicado: (2020)

Personalized radioiodine therapy for thyroid cancer patients with known disease
por: Jhiang, Sissy M, et al.
Publicado: (2021)

Radioiodine treatment of differentiated thyroid cancer despite history of ‘iodine allergy’
por: Puchalski, Adam R, et al.
Publicado: (2014)

Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
por: Esquerré-Lamare, Camille, et al.
Publicado: (2015)

Updates on the Management of Advanced, Metastatic, and Radioiodine Refractory Differentiated Thyroid Cancer
por: Tumino, Dario, et al.
Publicado: (2017)

Prevention of salivary gland dysfunction in patients treated with radioiodine for differentiated thyroid cancer: A systematic review of randomized controlled trials
por: Auttara-atthakorn, Arunrat, et al.
Publicado: (2022)

A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer
por: Zheng, Xiangqian, et al.
Publicado: (2021)

Basil
por: Collins, Wilkie, 1824-1889

Superficial myofibroblastoma of the vagina with a stalk: case report of a rare vaginal tumor with notable radiological findings
por: Tomita, Yui, et al.
Publicado: (2021)

Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy
por: Wadsley, Jon, et al.
Publicado: (2023)

Recombinant Human Thyrotropin-Aided Radioiodine Therapy in Tracheal Obstruction by an Invading Well-Differentiated Thyroid Carcinoma
por: Pontikides, Nickolaos, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5q5n86pvvri501i2jsl4oe7lme